Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 22.89%634.84M | 1.72%2.13B | 5.85%564.02M | -1.17%519.9M | 1.48%530.5M | 0.65%516.57M | 2.45%2.09B | 10.45%532.84M | 11.49%526.06M | -0.70%522.75M |
| Cost of revenue | 19.46%547.4M | 1.47%1.88B | 3.15%504.83M | -2.38%452.49M | 3.09%469.27M | 1.98%458.24M | 2.44%1.86B | 10.38%489.42M | 5.27%463.5M | -0.09%455.22M |
| Gross profit | 49.90%87.44M | 3.69%246.16M | 36.30%59.18M | 7.77%67.41M | -9.34%61.23M | -8.68%58.33M | 2.54%237.39M | 11.23%43.42M | 98.31%62.55M | -4.58%67.54M |
| Operating expense | -25.68%19.24M | 409.95%71.04M | 123.60%15.35M | -2.19%18.48M | -52.93%11.33M | -28.12%25.88M | -88.80%13.93M | -330.87%-65.04M | -53.68%18.89M | -35.49%24.07M |
| Selling and administrative expenses | ---- | -21.23%85.9M | ---- | ---- | ---- | ---- | -17.97%109.05M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | -11.85%17.65M | ---- | ---- | ---- | ---- | -9.10%20.02M | ---- | ---- | ---- |
| -General and administrative expense | ---- | -23.34%68.25M | ---- | ---- | ---- | ---- | -19.73%89.04M | ---- | ---- | ---- |
| Other operating expenses | 11.42%28.84M | -40.54%38.45M | 9.12%22.14M | -27.01%21.33M | -25.27%22.64M | -28.12%25.88M | -11.30%64.67M | 181.79%20.29M | -28.34%29.23M | -18.80%30.29M |
| Total other operating income | --9.6M | -66.64%53.31M | -92.04%6.79M | -72.40%2.85M | 81.67%11.31M | ---- | 96.04%159.79M | 6.70%85.32M | --10.33M | --6.23M |
| Operating profit | 110.20%68.2M | -21.63%175.12M | -59.58%43.84M | 12.08%48.94M | 14.80%49.9M | 16.43%32.44M | 108.48%223.46M | 898.16%108.46M | 572.65%43.66M | 29.89%43.47M |
| Net non-operating interest income (expenses) | 27.97%10.07M | 17.70%35.81M | 20.11%9.81M | 13.15%9.29M | 30.16%8.83M | 8.49%7.87M | 77.42%30.42M | 41.17%8.17M | 40.42%8.21M | 78.28%6.79M |
| Non-operating interest income | 17.17%10.42M | 0.74%38.46M | 2.94%9.98M | -0.32%9.91M | 10.04%9.69M | -8.75%8.89M | 40.03%38.18M | 13.81%9.69M | 15.41%9.94M | 42.74%8.8M |
| Non-operating interest expense | -66.05%347K | -27.33%960K | -88.87%170K | -64.50%612K | -57.69%853K | -58.97%1.02M | -0.30%1.32M | 125.19%1.53M | -37.56%1.72M | -14.58%2.02M |
| Total other finance cost | ---- | -73.64%1.7M | ---- | ---- | ---- | ---- | -26.80%6.44M | ---- | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 94.15%78.27M | -16.92%210.92M | -54.00%53.64M | 12.25%58.23M | 16.88%58.74M | 14.79%40.32M | 104.20%253.88M | 600.45%116.63M | 1,630.72%51.88M | 34.83%50.25M |
| Income tax | 5,552.07%9.21M | -45.65%11.21M | -87.28%979K | -26.73%3.74M | 143.37%6.66M | -103.32%-169K | 27.50%20.63M | 1,799.34%7.7M | 1.15%5.11M | -49.78%2.74M |
| Net income | 70.58%69.06M | -14.38%199.71M | -51.65%52.66M | 16.50%54.49M | 9.59%52.07M | 34.80%40.49M | 115.67%233.25M | 536.89%108.93M | 654.34%46.77M | 49.32%47.52M |
| Net income continuous operations | 70.58%69.06M | -14.38%199.71M | -51.65%52.66M | 16.50%54.49M | 9.59%52.07M | 34.80%40.49M | 115.67%233.25M | 536.89%108.93M | 654.34%46.77M | 49.32%47.52M |
| Noncontrolling interests | 54.53%16.01M | -33.29%45.93M | -64.81%9.13M | 2.73%14.4M | -21.64%12.04M | -23.36%10.36M | 47.07%68.85M | 189.46%25.95M | 49.18%14.02M | 13.89%15.37M |
| Net income attributable to the company | 76.09%53.05M | -6.46%153.78M | -47.54%43.53M | 22.40%40.09M | 24.52%40.03M | 82.38%30.13M | 168.04%164.4M | 919.71%82.97M | 283.69%32.76M | 75.40%32.15M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 76.09%53.05M | -6.46%153.78M | -47.54%43.53M | 22.40%40.09M | 24.52%40.03M | 82.38%30.13M | 168.04%164.4M | 919.71%82.97M | 283.69%32.76M | 75.40%32.15M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 76.59%0.267 | -6.55%0.7724 | -47.42%0.2193 | 22.16%0.2012 | 24.18%0.2008 | 81.95%0.1512 | 168.00%0.8265 | 919.80%0.4171 | 283.61%0.1647 | 75.38%0.1617 |
| Diluted earnings per share | 76.59%0.267 | -6.55%0.7724 | -47.42%0.2193 | 22.16%0.2012 | 24.18%0.2008 | 81.95%0.1512 | 168.00%0.8265 | 919.80%0.4171 | 283.61%0.1647 | 75.38%0.1617 |
| Dividend per share | 0 | 0.00%0.35 | 0.00%0.25 | 0 | 0.00%0.1 | 0 | 0.00%0.35 | 0.00%0.25 | 0 | 0.00%0.1 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.